Clinical Trials in Anaheim, CA

Browse 140 Anaheim Medical Studies Across 1040 Cities
88 Phase 3 Trial · 7632 Anaheim Clinics

Display Results

All

Most EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Clinical Trials in Anaheim, CA

Reviewed by Michael Gill, B. Sc.

Image of Preferred Primary Care Physicians in Uniontown, United States.

Phase-Based Progress Estimates

PF-07081532 20 Mg T2DMfor Diabetes Mellitus

The purpose of this study is to find out if PF-07081532 ("the active study drug"), is safe and helps treat people with obesity without diabetes to lose weight, and people with diabetes to keep their blood sugar in good control. Individuals diagnosed with diabetes that are on metformin or individuals with obesity without diabetes will be included in the study. Those participating in the diabetes part of the study, will receive either active study drug, placebo, or an approved treatment called Rybelsus. Those in the obesity part of the study, will receive either active study drug or placebo. The study will last for about 36 weeks except for the first 25% of the participants that enter in which case the study will last for approximately 48 weeks. during this time there will be visits every 4 weeks with phone calls in between.

Preferred Primary Care Physicians (+15 Sites)Pfizer CT.gov Call CenterPfizer

Image of Anaheim Clinical Trials LLC /ID# 250098 in Anaheim, United States.

Phase-Based Progress Estimates

Risankizumab Dose Afor Healthy Subjects (HS)

This trial will assess the safety of risankizumab and how it moves through the body. 198 adults will be enrolled and receive the drug through injections. They will be monitored for 10 days and followed up for 140 days to assess for any adverse events.

Anaheim Clinical Trials LLC /ID# 250098 (+5 Sites)ABBVIE INC.AbbVie

Image of Neighborhood Healthcare Institute of Health in Escondido, United States.

Phase-Based Progress Estimates

Tirzepatidefor Overweight

This trial will look at whether tirzepatide can reduce obesity-related health problems and death in adults.

Neighborhood Healthcare Institute of Health (+78 Sites)Call 1-877-CTLILLY (1-877-285-4559 or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Eli Lilly and Company

Image of Lenzmeier Family Medicine/CCT Research in Glendale, United States.

Phase-Based Progress Estimates

Quadrivalent Influenza ModRNA Vaccinefor Influenza, Human

This trial will compare the efficacy of a new quadrivalent influenza modRNA vaccine to a licensed inactivated influenza vaccine in healthy adults 18 years and older.

Lenzmeier Family Medicine/CCT Research (+99 Sites)Pfizer CT.gov Call CenterPfizer

Image of Anaheim Clinical Trials in Anaheim, United States.

Phase-Based Progress Estimates

Treatment A: Lecanemab 720 Mgfor Healthy Subjects (HS)

Waitlist Available

The primary purpose of this study is to demonstrate the bioequivalence (BE) of a single subcutaneous (SC) dose of lecanemab via vial and AI in healthy participants.

Waitlist Available

Anaheim Clinical TrialsEisai Inc.

Image of Clinical Research Atlanta in Stockbridge, United States.

Phase-Based Progress Estimates

BNT162b2 Bivalent (WT/OMI BA.1)for COVID19 (disease)

Waitlist Available

This trial is seeking to learn about the safety, tolerability and immunogenicity of two different RNA-based SARS-CoV-2 vaccine candidates given as a booster dose in adults, with or without a history of receiving prior doses of a COVID-19 vaccine.

Waitlist Available

Clinical Research Atlanta (+32 Sites)Pfizer CT.gov Call CenterBioNTech SE

Image of Proscience Research Group in Culver City, United States.

Phase-Based Progress Estimates

Aticrapantfor Anhedonia

1 Prior Treatment

This trial will compare the effectiveness of aticaprant vs. placebo as an addition to current antidepressant therapy in adults with major depressive disorder who have moderate-to-severe anhedonia.

1 Prior Treatment

Proscience Research Group (+34 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC

Image of Emad Ibrahim, Md, Inc in Redlands, United States.

Phase-Based Progress Estimates

Giredestrantfor Breast Cancer

This trial will compare two cancer treatments to see which is more effective in treating breast cancer that is Advanced or has Metastasized and is estrogen receptor and human epidermal growth factor receptor 2 positive.

Emad Ibrahim, Md, Inc (+23 Sites)Clinical TrialsGenentech, Inc.

Image of Alkermes Investigator Site in Long Beach, United States.

Phase-Based Progress Estimates

OLZ/SAMfor Schizophrenia

This trial compares the changes in body mass index (BMI) Z-score of patients following treatment with olanzapine/samidorphan versus olanzapine.

Alkermes Investigator Site (+6 Sites)David McDonnell, MDAlkermes, Inc.

Image of Pacific Cancer Medical Center in Anaheim, United States.

Phase-Based Progress Estimates

Palonosetron HCl Buccal Film 0.5 Mgfor Nausea

This trial is testing whether a long-acting anti-nausea drug is as effective when delivered by a buccal film compared to an IV injection.

Pacific Cancer Medical Center (+12 Sites)Xiamen LP Pharmaceutical Co., Ltd

Image of Emory University Hospital in Atlanta, United States.

Phase-Based Progress Estimates

HMPL-760for Waldenstrom Macroglobulinemia

This trial is testing a new drug, HMPL-760, on patients who have already been treated for a type of cancer called CLL/SLL or NHL. They're testing how safe and tolerable the drug is, as well as its efficacy.

Emory University Hospital (+11 Sites)Vijay Jayaprakash, MBBS, PHDHutchmed

Image of Alta Bates Summit Medical Center-Herrick Campus in Berkeley, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Stage IVA Lung Cancer AJCC v8

FDA Approved Drug

This trial is testing immunotherapy treatment with N-803 and pembrolizumab for advanced non-small cell lung cancer. N-803 may activate natural killer cells so that they can stimulate an immune response to help fight cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.

FDA Approved Drug

Alta Bates Summit Medical Center-Herrick Campus (+99 Sites)John M Wrangle

Image of SWOG in Portland, United States.

Phase-Based Progress Estimates

Cisplatinfor Relapse

FDA Approved Drug

This trial is comparing the effect of immunotherapy with atezolizumab in combination with standard chemotherapy versus standard therapy alone for the treatment of poorly differentiated extrapulmonary small cell neuroendocrine cancer.

FDA Approved Drug

SWOG (+99 Sites)David B Zhen

Image of BioXcel Clinical Research Site in Atlanta, United States.

Phase-Based Progress Estimates

BXCL501for Schizophrenia

FDA Approved Drug

This trial shows that BXCL501 is safe and effective in treating children and adolescents with bipolar disorder or schizophrenia who are experiencing acute agitation.

FDA Approved Drug

BioXcel Clinical Research Site (+5 Sites)Robert Risinger, MDCognitive Research Corporation

Image of Anaheim Clinical Trials in Anaheim, United States.

Phase-Based Progress Estimates

Phenelzinefor Healthy Subjects (HS)

FDA Approved Drug

This trial is designed to study the effect of different doses of tyramine on blood pressure in people who are taking rasagiline, phenelzine, or ozanimod. The trial will consist of three periods: daily escalating doses of tyramine until blood pressure is increased by at least 30 mm Hg (Period 1), rasagiline, phenelzine, or ozanimod at different doses (Period 2), and a final tyramine challenge (Period 3). There is also a follow-up phase during which participants will have two telephone calls.

FDA Approved Drug

Anaheim Clinical TrialsMassimo Attanasio, MDCelgene

Image of Medical Affiliated Research Center (MARC) in Huntsville, United States.

Phase-Based Progress Estimates

BNT162b2for COVID-19

Waitlist Available

FDA Approved Drug

This trial will assess the safety and efficacy of a booster dose of the BNT162b2 vaccine in adults who have received 2 doses of the vaccine at least 6 months prior. The trial will also assess the safety and tolerability of a single dose of the BNT162b2 vaccine in adolescents 12-17 years of age, as compared to a placebo control.

Waitlist Available

FDA Approved Drug

Medical Affiliated Research Center (MARC) (+58 Sites)Pfizer CT.gov Call CenterBioNTech SE

Image of Sarkis Clinical Trials in Gainesville, United States.

Phase-Based Progress Estimates

Seltorexantfor Psychosis, Involutional

No Cost For Treatment

This trial will test if Seltorexant is a safe and tolerable treatment for depression in adolescents when taken with an antidepressant.

No Cost For Treatment

Sarkis Clinical Trials (+11 Sites)Janssen Research & Development, LLC Clinical TrialJanssen Research & Development, LLC

Image of Children's Hospital of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Group 2, Arm D (dexamethasone, Nivolumab, Blinatumomab, MTX)for Down Syndrome

FDA Approved Drug

This trial is studying nivolumab in combination with blinatumomab to see how well it works compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia that has come back.

FDA Approved Drug

Children's Hospital of Alabama (+99 Sites)Stacy L Cooper

Image of Synergy San Diego in Lemon Grove, United States.

Phase-Based Progress Estimates

SEP-363856for Schizophrenia

This trial is to study the long-term safety of an investigational drug for people with schizophrenia. The study is open to males and females between 13-65 years old who have completed Study SEP361-301 or SEP361-302. The study will last one year and will be conducted at 80 study centers worldwide.

Synergy San Diego (+18 Sites)CNS Medical DirectorSunovion

Image of Fairbanks Memorial Hospital in Fairbanks, United States.

Phase-Based Progress Estimates

Ipilimumabfor Cancer

FDA Approved Drug

This trial is testing a new combination treatment for patients with untreated renal cell carcinoma. The usual treatment is immunotherapy with ipilimumab and nivolumab, followed by nivolumab alone. The new treatment adds cabozantinib to nivolumab after initial treatment with ipilimumab and nivolumab. It is not yet known if this new combination treatment is better than the usual treatment.

FDA Approved Drug

Fairbanks Memorial Hospital (+99 Sites)Tian Zhang

Image of Investigational Site Number 8400036 in Birmingham, United States.

Phase-Based Progress Estimates

Hepatitis B Vaccinefor Meningococcal Infections

FDA Approved Drug

This trial is testing whether a new vaccine is non-inferior to the current standard vaccine for infants and toddlers. It is also looking at the antibody response to the new vaccine and comparing it to the current standard.

FDA Approved Drug

Investigational Site Number 8400036 (+97 Sites)Clinical Sciences & OperationsSanofi Pasteur, a Sanofi Company

Image of Urological Associates of Southern Arizona, P.C . in Tucson, United States.

Phase-Based Progress Estimates

PF-06821497for Small Cell Lung Carcinoma

This trial is testing a new drug to treat adult patients with small cell lung cancer, castration resistant prostate cancer, or follicular lymphoma who have relapsed or are refractory to standard therapies.

Urological Associates of Southern Arizona, P.C . (+32 Sites)Pfizer CT.gov Call CenterPfizer

Image of Children's Hospital of Alabama in Birmingham, United States.

Phase-Based Progress Estimates

Cisplatinfor Extragonadal Embryonal Carcinoma

FDA Approved Drug

This trial is testing how well active surveillance, bleomycin, etoposide, carboplatin or cisplatin work in treating pediatric and adult patients with germ cell tumors.

FDA Approved Drug

Children's Hospital of Alabama (+99 Sites)A. L Frazier

Image of Katmai Oncology Group in Anchorage, United States.

Phase-Based Progress Estimates

Atezolizumabfor Lynch Syndrome

FDA Approved Drug

This trial is testing a combination of chemotherapy drugs with atezolizumab to see if it is more effective than chemotherapy alone in treating patients with stage III colon cancer. Atezolizumab is an immunotherapy drug that may help the body's immune system attack the cancer.

FDA Approved Drug

Katmai Oncology Group (+99 Sites)Frank A Sinicrope

Image of Anchorage Associates in Radiation Medicine in Anchorage, United States.

Phase-Based Progress Estimates

Pembrolizumabfor Adenocarcinoma of Lung

FDA Approved Drug

This trial looks at whether genetic testing can help select the best treatment for patients with early-stage non-small cell lung cancer.

FDA Approved Drug

Anchorage Associates in Radiation Medicine (+99 Sites)Geoffrey R Oxnard

25 Anaheim Clinical Trials Near Me

Top Cities for Anaheim Clinical Trials

Image of Los Angeles in California.

Los Angeles

147Active Trials

Kaiser Permanente Los Angeles Medical CenterTop Active Site

Image of Miami in Florida.

Miami

137Active Trials

University of Miami Miller School of Medicine-Sylvester Cancer CenterTop Active Site

Image of Anaheim in California.

Anaheim

134Active Trials

Kaiser Permanente-AnaheimTop Active Site